Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2007-02-15
2011-11-22
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C514S243000
Reexamination Certificate
active
08063208
ABSTRACT:
Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol of the formulaare provided. Also provided is a pharmaceutical composition comprising one or more crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol, as well as a method of using one or more crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol in the treatment of cancer and other proliferative diseases.
REFERENCES:
patent: 6670357 (2003-12-01), Leftheris et al.
patent: 6787545 (2004-09-01), Ohtani et al.
patent: 6867300 (2005-03-01), Godfrey, Jr. et al.
patent: 6869952 (2005-03-01), Bhide et al.
patent: 6908916 (2005-06-01), Mastalerz et al.
patent: 6916815 (2005-07-01), Vite et al.
patent: 6933386 (2005-08-01), Bhide et al.
patent: 6951859 (2005-10-01), Bhide et al.
patent: 6969717 (2005-11-01), Bhide et al.
patent: 7030118 (2006-04-01), Lombardo et al.
patent: 7064203 (2006-06-01), Gavai et al.
patent: 7102001 (2006-09-01), Swaminathan et al.
patent: 7102002 (2006-09-01), Cai et al.
patent: 7102003 (2006-09-01), Gavai et al.
patent: 7141571 (2006-11-01), Fink et al.
patent: 7297695 (2007-11-01), Fink et al.
patent: 2003/0232831 (2003-12-01), Dyckman et al.
patent: 2004/0229877 (2004-11-01), Leftheris et al.
patent: 2005/0182058 (2005-08-01), Fink et al.
patent: 0 713 876 (1996-05-01), None
patent: WO 98/08847 (1998-03-01), None
patent: WO 00/71129 (2000-11-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 03/090912 (2003-11-01), None
patent: WO 2004/009784 (2004-01-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Gautschi et al., Clin. Cancer Res., 14(6), 1639-1648, 2008.
Mountzios et al., Cancer Treatments Reviews, 34, 175-182, 2008.
Mass, R. D., Int. J. Radiation Oncology Bio. Phys. vol. 58(3): 932-940, 2004.
Fabbro et al. Pharmacology & therapeutics 93, 79-98, 2002.
U.S. Appl. No. 60/620,784, filed Oct. 21, 2004, Gavai et al.
Ewald, H. et al., “Reaktionen von 1,2,4-Triazinen mit Acetylendicarbonsäure-dimethylester”, Liebigs Ann. Chem., pp. 1718-1724 (1977).
Hunt, J.T. et al., “Discovery of the Pyrrolo[2,1-f][1,2,4]triazine Nucleus as a New Kinase Inhibitor Template”, J. Med. Chem., vol. 47, No. 16, pp. 4054-4059 (2004).
Migliara, O. et al., “Synthesis of a New Bridgehead Nitrogen Heterocyclic System. Pyrrolo[2,1-f]-1,2,4-triazine Derivatives”, J. Heterocyclic Chem., vol. 16, pp. 833-834 (1979).
Neunhoeffer, H. et al., “Cycloadditionen mit Methoxy- und Dialkylamino-1,2,4-triazinen”, Liebigs Ann. Chem., pp. 1413-1420 (1977).
Patil, S.A. et al., “Synthesis of Pyrrolo[2,1-f][1,2,4]triazine Congeners of Nucleic Acid Purines via theN-Amination of 2-Substituted Pyrroles”, J. Heterocyclic Chem., vol. 31, pp. 781-786 (1994).
Quintela, J.M. et al., “A Ready One-pot Preparation for Pyrrolo[2,1-f][1,2,4]triazine and Pyrazolo[5,1-c]pyrimido[4,5-e]-[1,2,4]triazine Derivatives”, Tetrahedron, vol. 52, No. 8, pp. 3037-3048 (1996).
Tsi-Ping et al., TIPS, vol. 16:5766 (1995).
de La Matte Rouge, Thibault et al., Cancer Research, vol. 67, No. 13, pp. 6253-6262 ( 2007).
http://Clinicaltrials.gov , Search Results for BMS-690514 (Dec. 22, 2008).
Norris Derek J.
Wei Chenkou
Balasubramanian Venkataraman
Bristol--Myers Squibb Company
Wang Ying
LandOfFree
Crystalline forms of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287285